World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
110
Citations
57180
World Ranking
876
National Ranking
530

Medicine

D-Index
111
Citations
60249
World Ranking
5255
National Ranking
2835

Mary Sano publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mary Sano sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 548 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mary Sano D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mary Sano sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 111 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Mary Sano is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research primarily spans the field of Medicine, with a focus on Psychiatry and Mental Health, Physiology, Neurology, Clinical Psychology, and Epidemiology.

The main topics investigated by Mary Sano include:

  • Dementia and Cognitive Impairment Research
  • Alzheimer's disease research and treatments
  • Traumatic Brain Injury Research
  • Frailty in Older Adults
  • Schizophrenia research and treatment
  • Nutritional Studies and Diet
  • Intensive Care Unit Cognitive Disorders

Mary Sano has contributed extensively to scientific literature with recent publications such as:

  • "Diagnostic criteria for apathy in neurocognitive disorders," 2021, Alzheimer's & Dementia
  • "Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease," 2021, Brain
  • "Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposure," 2020, Molecular Psychiatry
  • "Criteria for Psychosis in Major and Mild Neurocognitive Disorders: International Psychogeriatric Association (IPA) Consensus Clinical and Research Definition," 2020, American Journal of Geriatric Psychiatry
  • "MicroRNA-195 rescues ApoE4-induced cognitive deficits and lysosomal defects in Alzheimer's disease pathogenesis," 2020, Molecular Psychiatry

The frequent co-authors collaborating with Mary Sano include Carolyn W. Zhu, Judith Neugroschl, Sam Gandy, Michal Schnaider Beeri, and Amy Aloysi.

Mary Sano's research is consistently published in several key venues such as:

  • Alzheimer's & Dementia
  • American Journal of Geriatric Psychiatry
  • International Psychogeriatrics
  • Alzheimer's & Dementia Diagnosis Assessment & Disease Monitoring
  • Journal of the American Medical Directors Association

Best Publications

  • A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study

    Mary Sano;Christopher Ernesto;Ronald G. Thomas;Melville R. Klauber

  • Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment

    Ronald C. Petersen;Ronald G. Thomas;Michael Grundman;David Bennett

  • Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

    Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang

  • Length of clinical trials of dementia drugs : Position paper from the international working group on harmonization of dementia drug guidelines

    Douglas Galasko;David Bennett;Mary Sano;Chris Ernesto

  • Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial

    R. A. Mulnard;C. W. Cotman;C. Kawas;C. H. Van Dyck

  • Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.

    Michael Grundman;Ronald C. Petersen;Steven H. Ferris;Ronald G. Thomas

  • Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities.

    T K Tatemichi;D W Desmond;Y Stern;M Paik

  • Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression: A Randomized Controlled Trial

    Paul S. Aisen;Kimberly A. Schafer;Michael Grundman;Eric Pfeiffer

  • Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

    Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez

  • The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set.

    Duane L. Beekly;Erin M. Ramos;William W. Lee;Woodrow D. Deitrich

  • Development of cognitive instruments for use in clinical trials of antidementia drugs: Additions to the Alzheimer's Disease Assessment Scale that broaden its scope.

    Richard C. Mohs;David Knopman;Ronald C. Petersen;Steven H. Ferris

  • Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease The TEAM-AD VA Cooperative Randomized Trial

    Maurice W. Dysken;Mary Sano;Sanjay Asthana;Julia E. Vertrees

  • Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community.

    Devangere P. Devanand;Mary Sano;Mingxin Tang;Stuart Taylor

  • Multiscale Analysis of Independent Alzheimer's Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus.

    Benjamin Readhead;Jean Vianney Haure-Mirande;Cory C. Funk;Matthew A. Richards

  • Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

    Rachelle S Doody;Svetlana I Gavrilova;Mary Sano;Ronald G Thomas

  • Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions

    Vivianna M. Van Deerlin;Patrick M A Sleiman;Maria Martinez-Lage;Maria Martinez-Lage;Alice Chen-Plotkin

  • High-Dose B Vitamin Supplementation and Cognitive Decline in Alzheimer Disease: A Randomized Controlled Trial

    Paul S. Aisen;Lon S. Schneider;Mary Sano;Ramon Diaz-Arrastia

  • Dementia after stroke Baseline frequency, risks, and clinical features in a hospitalized cohort

    T. K. Tatemichi;D. W. Desmond;R. Mayeux;M. Paik

  • A randomized controlled trial of prednisone in Alzheimer’s disease

    Paul S. Aisen;K. L. Davis;J. D. Berg;K. Schafer

  • A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.

    P S Aisen;K L Davis;J D Berg;K Schafer

Frequent Co-Authors

Yaakov Stern
Yaakov Stern Columbia University
Paul S. Aisen
Paul S. Aisen University of Southern California
Jeremy M. Silverman
Jeremy M. Silverman Icahn School of Medicine at Mount Sinai
Richard Mayeux
Richard Mayeux Columbia University
Ronald G. Thomas
Ronald G. Thomas University of California, San Diego
Lon S. Schneider
Lon S. Schneider University of Southern California
Steven H. Ferris
Steven H. Ferris New York University
Diane M. Jacobs
Diane M. Jacobs University of California, San Diego
Karen Marder
Karen Marder Columbia University
James Schmeidler
James Schmeidler Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees can open alternative pathways for those interested in medicine, but seeking flexibility or advanced roles beyond the traditional MD. Many healthcare careers now offer reputable online programs that make it easier to balance studies with work and life commitments.

For registered nurses wanting to specialize in mental health, the fastest psychiatric nurse practitioner program options provide an accelerated route to becoming a psychiatric mental health nurse practitioner. This role is in high demand, offering both clinical autonomy and excellent job prospects.

Those interested in leadership, operations, or the business side of healthcare may consider health administration degrees online. These programs equip students with the skills needed for management roles in hospitals, clinics, and public health organizations.

Earning a master's in healthcare administration online can further advance your career, qualifying graduates for higher-level executive and policy-making positions.

Finally, for nurses aiming to reach the top of clinical practice, least expensive dnp programs provide an accessible route to the Doctor of Nursing Practice, a terminal degree in the nursing field.

Best Scientists Citing Mary Sano

Trending Scientists

Recently Published Articles